Nanobac Pharmaceuticals Google Group

Human-derived nanoparticles and vascular response to injury in rabbit carotid arteries: Proof of principle

2008-02-22T14:31:51Z

Friday, February 22, 2008
International Journal of Nanomedicine

Human-derived nanoparticles and vascular response to injury in rabbit
carotid arteries: Proof of principle

Maria A K Schwartz1, John C Lieske2, Vivek Kumar2, Gerard Farell-
Baril2, Virginia M Miller1,3

1Departments of Physiology and Biomedical Engineering, Internal

Association of Nanoparticle and Kidney Stone Formation

2008-02-19T17:09:38Z

Nanobac Announces Publication of Association of Nanoparticle and
Kidney Stone Formation

Results May Change Approach to Medical Management of Kidney Stones

Last update: 11:28 a.m. EST Feb. 19, 2008

TAMPA, FL, Feb 19, 2008 (MARKET WIRE via COMTEX) -- Nanobac
Pharmaceuticals Inc. ("Nanobac" or "the Company") announces

Legal Team to Enforce Patent Rights

2008-02-07T14:39:13Z

Nanobac Pharmaceuticals Inc. Engages Legal Team to Enforce Patent
Rights

Last update: 9:15 a.m. EST Feb. 7, 2008

TAMPA, Fla., Feb 07, 2008 (BUSINESS WIRE) -- Nanobac Pharmaceuticals
Inc. ("Nanobac" or "the Company") is pleased to announce that it has
engaged Guy Ricciardulli for services related to claims for damages,

Re: Nanobac Announces European Heart Journal Publication of Association Between Calcifying Nanoparticles and Aortic Stenosis

2008-01-22T22:04:39Z

European Heart Journal Advance Access published online on January 12,
2008
European Heart Journal, doi:10.1093/eurheartj/ehm592

Published on behalf of the European Society of Cardiology. All rights
reserved. (c) The Author 2008. For permissions please email:
journals.permissi...@oxfordjou rnals.org

Nanobac Announces European Heart Journal Publication of Association Between Calcifying Nanoparticles and Aortic Stenosis

2008-01-22T16:07:04Z

Nanobac Announces European Heart Journal Publication of Association
Between Calcifying Nanoparticles and Aortic Stenosis

Last update: 10:59 a.m. EST Jan. 22, 2008

TAMPA, Fla., Jan 22, 2008 (BUSINESS WIRE) -- Nanobac Pharmaceuticals
Inc. ("Nanobac" or "the Company") announces the multicenter

Ultrafine Air Pollution May Cause Heart Disease

2008-01-21T16:39:36Z

Ultrafine Air Pollution May Cause Heart Disease, Researchers Say

January 21, 2008 5:36 a.m. EST

Paul Icamina - AHN News Writer

Los Angeles, CA (AHN) - Air pollution can be bad for the heart.
Similar to the hazards of second hand smoke, nanoparticles in air
pollution may promote hardening of the arteries and cause heart

Nanobac Announces Baylor College of Medicine Initial Results for Nanoparticle and Gall Stone Formation Study

2008-01-15T22:41:19Z

Nanobac Announces Baylor College of Medicine Initial Results for
Nanoparticle and Gall Stone Formation Study
Jan 15 2008, 9:23 AM EST

News source: Business Wire

Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company")
announces that scientists at the Baylor College of Medicine, working

Nanobac Pharmaceuticals Inc. to Present at the Fall Life Sciences Conference in New York

2007-10-29T18:00:27Z

Nanobac Pharmaceuticals Inc. to Present at the Fall Life Sciences
Conference in New York Premier Event to Be Held November 1st
NNBP today announced that it has been invited to present at Friedland
Investment Events' Life Sciences Conference in New York. The
Conference will be held November 1st at the DoubleTree Hotel Times

Microscopic Observation of Self-Propagation of Calcifying Nanoparticles (Nanobacteria)

2007-10-10T22:07:21Z

Title: Microscopic Observation of Self-Propagation of Calcifying
Nanoparticles (Nanobacteria)
Author(s): Mathew, Grace; McKay, David S.; Ciftcioglu, Neva
Abstract: Biologists typically define living organisms as carbon and
water-based cellular forms with self-replication" as the fundamental
trait of the life process. However, this standard dictionary

Re: Calgenex tackles calcification

2007-10-03T15:33:57Z

Calgenex Introduces Calci-CLEAR™ Line of Dietary Supplements:
Addresses Calcification of Arteries and Soft Tissues
TAMPA, Fla. (BusinessWire EON) April 11, 2007 -- Calgenex Corporation
announced today the introduction of Calci-CLEAR, an exclusive line of
dietary supplements addressing calcification of the soft tissues

Re: Calgenex tackles calcification

2007-10-03T15:30:08Z

Calgenex Names Joseph Jacobs, M.D., as Consulting Medical Director
2006-09-14 - Calgenex Corporation
TAMPA, Fla.--(BUSINESS WIRE)--Sept. 14, 2006--Calgenex Corporation
today announced that Joseph Jacobs, M.D., MBA, has joined the
nutraceutical and personal care products company in the position of
Consulting Medical Director.

Re: Calgenex tackles calcification

2007-10-03T15:28:11Z

Nanobac Pharmaceuticals Acquires Option to License Calgenex Technology
to Treat Atherosclerosis and Prostatitis
Wednesday October 3, 9:15 am ET
TAMPA, Fla.--(BUSINESS WIRE)--Nanobac Pharmaceuticals Inc. (OTCBB:NNBP
- News; "Nanobac" or "the Company") announced today that it signed an
agreement with Calgenex granting Nanobac an option to assess Calgenex'

Calgenex tackles calcification

2007-10-03T15:26:21Z

Calgenex tackles calcification
By Clarisse Douaud
9/13/2006 - New manufacturer and marketer Calgenex Corporation is
taking the condition-specific approach to supplementation to a very
specific level - tackling soft tissue calcification with a range of
products.
In an effort to set themselves apart from the crowd, more and more

Continuation of Space Act Agreement with NASA

2007-09-22T20:28:57Z

Nanobac Pharmaceuticals Announces Continuation of Space Act Agreement
with NASA: NASA to Study Characterization of the Physical and Chemical
Properties of Calcifying Nano Particles and Their Role in Calcifying
Diseases
Last Update: 9:15 AM ET Sep 18, 2007
TAMPA, Fla., Sep 18, 2007 (BUSINESS WIRE) -- Nanobac Pharmaceuticals

Agreement with American Health Associates

2007-09-12T13:23:26Z

Agreement with American Health Associates
Nanobac Pharmaceuticals Inc. Signs Agreement with American Health
Associates Clinical Laboratories to Provide Calcifying Nanoparticle
Tests in the United States
"Test Available 4th Quarter 2007"
Last Update: 9:15 AM ET Sep 12, 2007
TAMPA, Fla., Sep 12, 2007 (BUSINESS WIRE) -- Nanobac Pharmaceuticals